p21 is a potent inhibitor of cyclin-dependent kinases capable of arresting cell cycle progression. p21 is primarily regulated at the transcriptional level by several transcription factors, including p53. Previously, we reported that certain members of the E2F family of transcription factors may activate p21 transcription via a p53-independent mechanism. To further elucidate the consequences of E2F-1-regulated induction of p21, we developed cell lines with a tamoxifen-dependent form of E2F-1. We confirmed direct interaction of E2F-1 with the proximal region of the p21 promoter. Interestingly, elevated E2F-1 activity was sufficient to arrest a substantial subset of cells in S phase and this effect was correlated to and dependent on the induction of p21 protein. Since E2F proteins control genes required for cell cycle progression and are activated by various oncogenic events, we believe that the p21-dependent arrest described in this report represents an additional mechanism that guards against unrestricted cell proliferation.
The E2F transcription factors activate a number of genes responsible for DNA replication and for S phase progression (Nevins, 2001) , and overexpression of E2F-1 in quiescent cells induces S phase progression (Johnson et al., 1993) . Paradoxically, deregulated expression of an E2F-1 mutant that cannot be inactivated by cyclinA/ Cdk2 during S phase of cell cycle leads to S phase arrest (Shan and Lee, 1994; Krek et al., 1995; Logan et al., 1995) . Similarly, a novel retinoid CD437 that induces E2F-1 activity and inhibits cyclinA/cdk2 activity also stimulates S phase arrest (Zhang et al., 2000; Farhana et al., 2002) . However, the mechanism underlying E2F-1-dependent S phase arrest is not well understood.
The gene encoding the CDK inhibitor p21 is a major target for transactivation by the tumor suppressor p53 (El-Deiry et al., 1993; Harper et al., 1993) . p21 has been shown to inhibit proliferation both in vitro and in vivo, and introduction of p21 expression constructs into normal and tumor cell lines typically results in cell cycle arrest in G1 (reviewed in Gartel et al., 1996; . p21 is required for p53-dependent G1 arrest (Brugarolas et al., 1995; Deng et al., 1995; Waldman et al., 1995) and for maintaining p53-dependent G2 arrest in response to DNA damage (Bunz et al., 1998) . We and others previously showed that p21 is highly inducible by E2F-1 and E2F-3 in transient transfection assays through sequences between À119 and þ 16 bp of the p21 promoter, by a p53-independent mechanism Hiyama et al., 1998) . Here, we show that constitutive expression of E2F-1 induces endogenous p21 expression and that p21 is responsible for E2F-1-dependent S phase cell cycle arrest.
To test functional consequences of deregulated expression of E2F-1 and to determine the role of p21 induction by E2F-1, we used an inducible E2F-1 derivative, consisting of a fusion between human E2F-1 and a modified ligand-binding domain of a human estrogen receptor (E2F-1-ER). A retroviral vector encoding E2F-1-ER (Vigo et al., 1999; Muller et al., 2001 ) (gift from Dr Kristian Helin, European institute of Oncology, Milan, Italy) was introduced into p21 À/À 3T3 cells (gift from Brian Dynlacht, New York University, USA) and the p21 þ / þ NIH3T3 cell line to generate p21 À/À 3T3-E2F-1-ER and NIH3T3-E2F-1-ER cells, respectively. The expression of E2F-1-ER in selected clones was confirmed by immunoblotting with antibodies that specifically recognize E2F-1 (Figure 1a ). The addition of 4-hydroxytamoxifen (4-HT) activates the E2F-1-ER fusion protein, which is constitutively expressed in these cell lines, by derepressing the hormone-binding domain of the fusion protein (Vigo et al., 1999 ) and provides rapid control over the activity of the exogenous E2F-1. We compared the levels of endogenous p21 mRNA and protein in untreated NIH3T3-E2F-1-ER cells and in the cells where E2F-1 was induced by the addition of 4-HT. Using semiquantitative RT-PCR, we found that endogenous p21 transcription was induced after the activation of E2F-1-ER by 4-HT (Figure 1b ). Using immunoblotting, we found that endogenous p21 protein levels were increased more than fivefold after the activation of E2F-1 activity by 4-HT (Figure 1c ). The addition of 4-HT to p21 À/À 3T3-E2F-1-ER cells also led to the elevation of E2F-1 activity as evidenced by elevated expression of caspase-7, a well-characterized E2F-1 target (Ma et al., 2002) (Figure 1d) .
Previously, we found that direct binding of E2F-1 to DNA is required for the induction of p21 in transient transfection assay . To investigate the regulation of the endogenous p21 gene by E2F-1 in vivo, we examined the interaction of E2F-1 with the p21 promoter using the chromatin immunoprecipitation (ChIP) assay. Crosslinked E2F-1-DNA complexes were immunoprecipitated by an anti-E2F-1 antibody and the relative amount of precipitated p21 promoter DNA was determined by PCR amplification with specific primers (Figure 2a) . Control experiments without antibody or with p21 antibody gave rise to a low level of background signal ( Figure 2a) . We isolated the band that corresponds to specific PCR product from the agarose gel ( Figure 2b ) and determined its sequence. Comparison of the obtained sequence with known sequence of the mouse p21 promoter confirmed their identity ( Figure 2b ). These data suggest that E2F-1 directly binds to the proximal region of the p21 promoter in vivo.
We investigated the cell cycle consequences of E2F-1 activation in p21
3T3-E2F-1-ER and NIH3T3-E2F-1-ER cells. Using a procedure for simultaneous flow cytometric measurement of cellular DNA content and amount of bromodeoxyuridine (BrdU) incorporated into cellular DNA (Dolbeare et al., 1983) , we found that induction of E2F-1 activity in NIH3T3-E2F-1-ER Figure 2 E2F-1 binds to the proximal p21 promoter in vivo. (a) ChIP assay was performed in accordance with (Takahashi et al., 2000) before and after the induction of E2F-1 activity by HT. Crosslinked E2F-1-DNA complexes were immunoprecipitated by an anti-E2F-1 antibody (sc-193; Santa Cruz) and the relative amount of precipitated p21 promoter DNA was determined by PCR amplification with specific primers: forward primer, CAC AGT TGG TCA GGG ACA GA (À310 to À290); reverse primer, CAG GAC CAA CCC ACT CCT T (À87 to À68). Control experiments were performed without antibody or with p21 antibody (Cat 556431; BD Pharmingen). (b) Alignment of PCR product sequence from ChIP assay with the mouse p21 promoter sequence is shown. The locations of primers used for ChIP assay are indicated. Also shown are the three different E2F-binding sites (Hiyama et al., 1998) and the p21 transcriptional start site 3T3-E2F-1-ER cell lines. Western blot analysis of whole-cell lysates using antibodies specific for E2F-1 protein shows high expression levels of E2F-1-ER fusion protein in NIH3T3 and p21 À/À 3T3 cells.
NIH3T3-E2F-1-ER and p21
À/À 3T3-E2F-1-ER cell lines were grown in phenol-red-free Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Atlanta Biologicals), penicillin and streptomycin at 371C in 5% CO 2 . Cells at 40-50% confluence were treated either with 10 ml of 1mM hydroxytamoxifen (HT) or 10 ml of ethanol (Et) as indicated, and harvested 24 h later in RIPA buffer. Cell lysates (30 mg) were electrophoresed on an 8% SDS-polyacrylamide gel and transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, USA). Immunoblotting was performed as indicated with either E2F-1 antibody (sc-193; Santa Cruz, CA, USA) or b-actin antibody (A-5441; Sigma). (b) E2F-1 transcriptionally induces p21 in NIH3T3-E2F-1-ER cells. Total RNA was extracted from either Et or 4-HT treated cells using the RNeasy Mini kit (Qiagen Inc., CA, USA). cDNA was synthesized from 2 mg of total RNA using the Superscript first strand synthesis system (Invitrogen). For amplification of cDNA, primers for mouse p21 (upstream primer, GCA GAT CCA CAG CGA TAT CC; downstream primer, ACA CCA GAG TGC AAG ACA GC) or primers for b 2 -microglobulin (upstream primer, ATG GCTCGC TCG GTG ACC CTA G; downstream primer, TCA TGA TGC TTG ATC ACA TGT CTC G) were used. The annealing temperature for both PCR sets of primers was 661C, and the number of cycles used was 30 and 25 for p21 and b 2 -microglobulin, respectively. Amplified products were separated on a 2% agarose gel and visualized with ethidium bromide staining. (c) E2F-1 induces p21 protein levels in NIH3T3-E2F-1-ER cells. Lysates from cells treated with Et or HT were resolved on a 15% SDS-polyacrylamide gel and transferred to a PVDF membrane as described above. p21 protein levels were detected using mouse monoclonal anti-p21 antibody (Cat 556431; BD Pharmingen) and b-actin levels were detected with b-actin antibody (A-5441; Sigma). (d) E2F-1 transcriptionally induces caspase-7 in p21 À/À 3T3-E2F-1-ER cells. To check if the E2F-1-ER fusion protein is functional in p21 À/À 3T3-E2F-1-ER cell line, cDNA was prepared as described above and examined for the levels of caspase-7 (upstream primer, CCG AGT GCC CAC TTA TCT GT; downstream primer, GCC ATC TTT CCC GTA AAT CA; annealing temperature, 661C; number of cycles, 28). Caspase-7 is one of the major transcriptional targets of E2F-1 in fibroblasts (Ma et al., 2002) . Levels of b 2 -microglobulin were assessed as internal control
E2F-1 dependent S phase arrest is mediated by p21
SK Radhakrishnan et al cells leads to the appearance of a large population of nonreplicating (BrdU-negative) cells with DNA content corresponding to S phase (Figure 3a and b) , suggesting that these cells underwent an S phase arrest. In contrast, after conducting similar experiments in p21
3T3-E2F-1-ER cells, we found that induction of E2F-1 activity does not lead to S phase arrest in these cells and, in fact, leads to an increase in the fraction of cells actively replicating DNA (Figure 3c and d) . These data suggest that p21 induction by constitutive E2F-1 leads to S phase cell cycle arrest. We concluded that the propensity of constitutive E2F to drive cells into S phase is counteracted by simultaneous induction of p21, which effectively blocks DNA replication. Similarly, the novel retinoid CD437 that induces simultaneous increase of E2F-1 activity and S phase arrest also induces fourfold elevation of p21 (Zhang et al., 2000) .
To examine how p21 induces S phase arrest in NIH3T3-E2F-1-ER cells, we induced E2F-1 activity by the addition of 4-HT, and subjected cell lysates to immunoprecipitation with p21 antibodies followed by Western blotting with antibodies to different cell cycle proteins (Figure 4a ). We found that p21 was specifically associated with cyclin E and cdk2 (Figure 4a ), but not with cyclin D1, cyclin A, cdk4 or PCNA (data not shown). In addition, we found that cyclin E is overexpressed in NIH3T3-E2F-1-ER cells after the induction of E2F-1 activity, which is not surprising, since cyclin E is a well-known target of E2F-1 (Ohtani et al., 1995) (Figure 4a) . Interestingly, constitutive overexpression of cyclin E also leads to S phase arrest (Spruck et al., 1999) . Accordingly, we found that the addition of 4-HT leads to the inhibition of cdk2 kinase activity in the À/À 3T3-E2F-1-ER cell lines were treated either with Et or HT as indicated and harvested 24 h later in IP buffer (20 mM HEPES, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 100 mM NaF, 10 mM Na 4 P 2 O 7 , 1mM Na 3 VO 4 , 0.2 mM PMSF) supplemented with protease inhibitor tablet (Roche Applied Sciences). Total protein (750 mg) was used for the immunoprecipitation (IP) experiment with anti-p21 antibody (Cat 556431; BD Pharmingen). Cdk2 (sc-163) and cyclin E (sc-481) antibodies were obtained from Santa Cruz Inc, CA, USA. The same blot when probed with cyclin A antibody (sc-596, Santa Cruz), PCNA antibody (sc-56; Santa Cruz), cyclin D1 antibody (MS-210-P1; Neomarkers) or cdk4 antibody (sc-260; Santa Cruz) showed the appropriate bands in the cell lysates, while no bands were detected in the IP lanes (data not shown). (b) NIH3T3-E2F-1-ER and p21 À/À 3T3-E2F-1-ER cell lines were treated either with Et or HT as indicated and harvested 24 h later. Cell lysates (800 mg) were subjected to IP with cdk2 antibodies as described above. Half of the beads were washed thrice with IP wash buffer (20 mM HEPES, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 100 mM NaF, 10 mM Na 4 P 2 O 7 ), boiled with 15 ml of 2Â sample buffer and loaded on to a SDSpolyacrylamide gel. Proteins were transferred to PVDF membrane and probed with cdk2 antibody to assess the levels of cdk2 protein pulled down. The other half of the IP beads were washed twice in histone wash buffer (25 mM Tris-Hcl pH 7.5, 70 mM NaCl, 10 mM MgCl 2 , 1 mM DTT) and incubated at 371C in 30 ml of histone assay solution (0.1 mg/ml histone H1, 10 mM ATP, 0.2 mCi/ml [ 32 P]gATP) for 30 min. The reaction was terminated with 15 ml of 4 Â sample buffer and loaded on to a SDS-polyacrylamide gel. The gel was dried and exposed to X-ray film E2F-1 dependent S phase arrest is mediated by p21 SK Radhakrishnan et al presence of p21 (Figure 4b ). In contrast, in p21-null cells, induction of E2F-1 activity led to the induction of cdk2 kinase activity (Figure 4b ) and to an increase in the fraction of dividing cells in S phase of cell cycle (Figure 3d) . Our results support the data of Ogryzko et al. (1997) that p21 retards S phase progression by the inhibition of cyclin-dependent kinases (Ogryzko et al., 1997) . While p21-mediated inhibition of cdk2 could be one of the factors contributing to the S phase arrest, we cannot rule out other contributions of p21 to this process.
E2F family members control the expression of the key factors required for cell proliferation. Elevation of E2F-1 activity is a common consequence of various oncogenic events, such as activation of Ras, Raf and Akt (Gille and Downward, 1999) or loss of Rb (Tsai et al., 1998; Yamasaki et al., 1998) . Forced expression of E2F, however, is often incompatible with continuous cell proliferation (Shan and Lee, 1994; Krek et al., 1995; Logan et al., 1995) , implying the presence of specific mechanisms that limit uncontrolled cell proliferation. Our observations point to a p21-dependent S phase arrest as one such mechanism and indicate the importance of the status of p21 protein for the cell cycle consequences of E2F activation.
